Psychiatric Comorbidities Associated With Migraine
Episodic Migraine Prophylaxis Panic Disorder
American Academy of Neurology and
American Psychiatric Association (2009)
American Headache Society (2012)
Grade A Evidence Usual Therapeutic Grade A Evidence Usual Therapeutic
(Established Efficacy) Dose/Day† (Established Efficacy) Dose/Day†
β‐blockers Antidepressants
Propranolol 40‐240 mg Citalopram;
20‐40 mg
fluoxetine (SSRI)
Metoprolol 100‐200 mg
Escitalopram (SSRI) 10‐20 mg
Timolol 20‐30 mg
Fluvoxamine (SSRI) 100‐200 mg
Anticonvulsants Paroxetine (and
Paroxetine CR) 20‐40 mg (25‐50 mg)
Divalproex/valproate 500‐1500 mg (SSRIs)
Topiramate 50‐200 mg Sertraline (SSRI) 100‐200 mg
Grade B Evidence Usual Therapeutic Venlafaxine ER
150‐225 mg
(Likely Efficacious) Dose/Day† (SNRI)
Grade A Evidence
Usual Therapeutic
(But With Prescribing
Antidepressants Dose/Day†
Cautions)
Amitriptyline
25‐150 mg
(tricyclic) Tricyclic
Antidepressants
Venlafaxine (SNRI) 20‐200 mg
Imipramine 100‐300 mg
β‐blockers
Clomipramine 50‐150 mg
Atenolol 50‐200 mg
Benzodiazepines
Nadolol 80‐240 mg
Alprazolam 2‐4 mg¶
Clonazepam
© 2018 American Academy of Neurology Institute 1